A Michigan cannabis grower proved breach of contract and won a $31.8 million jury verdict—only to lose it on appeal. The Sixth Circuit held that a federal court could not enforce an agreement requiring conduct prohibited by the Controlled Substances Act. The decision offers a stark warning about forum selection, federal illegality, medical-use limitations, and remedies in cannabis contracts.
Five bills moving through the California legislature right now could reshape how DCC investigates violations, what gets tested and disclosed at retail, and what cannabis packaging can even look like. This post breaks down AB 1826, AB 1965, AB 2249, AB 2532, and AB 2537 in plain terms, explains how they interlock, and offers a practical compliance checklist for operators who want to get ahead of these changes before final enactment.
Rescheduling has reshaped the legal landscape for California Cannabis businesses, but many existing contracts haven't caught up. This post breaks down where supply, licensing, and investment agreements now fall short—covering gaps in DEA registration language, license conversion triggers, and 280E-related representations—and offers a practical framework for reviewing and updating agreements before those gaps become disputes.
Federal rescheduling turned California cannabis license designations into real strategy decisions, not just paperwork. This post explains when and how to convert or split A/M licenses, why medical vs adult-use separation now matters for 280E and DEA planning, and why every link in the supply chain needs its own clearly defined medical channel.
Federal rescheduling has finally arrived, but it didn’t magically solve everything for California cannabis businesses. Instead, it created a new set of decisions: whether to pursue DEA registration as a medical operator, how and when to restructure DCC licenses, and what 280E relief actually looks like for mixed medical/adult use companies. This article walks through the concrete steps California operators should take now — including what to do if you missed the initial DEA registration window.
